A citation-based method for searching scientific literature

Slobodan Culina, Christian Boitard, Roberto Mallone. Clin Dev Immunol 2011
Times Cited: 28







List of co-cited articles
293 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes.
Spiros Fourlanos, Christine Perry, Shane A Gellert, Emanuela Martinuzzi, Roberto Mallone, Jeanne Butler, Peter G Colman, Leonard C Harrison. Diabetes 2011
79
42

Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
Vedran Brezar, Jean-Claude Carel, Christian Boitard, Roberto Mallone. Endocr Rev 2011
45
42

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
Jay S Skyler, Jeffrey P Krischer, Joseph Wolfsdorf, Catherine Cowie, Jerry P Palmer, Carla Greenbaum, David Cuthbertson, Lisa E Rafkin-Mervis, H Peter Chase, Ellen Leschek. Diabetes Care 2005
390
32

The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Emanuela Martinuzzi, Giulia Novelli, Matthieu Scotto, Philippe Blancou, Jean-Marie Bach, Lucy Chaillous, Graziella Bruno, Lucienne Chatenoud, Peter van Endert, Roberto Mallone. Diabetes 2008
76
32




Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetes.
Sandrine Luce, François Lemonnier, Jean-Paul Briand, Joel Coste, Najiba Lahlou, Sylviane Muller, Etienne Larger, Benedita Rocha, Roberto Mallone, Christian Boitard. Diabetes 2011
27
25

Immunotherapy of type 1 diabetes: where are we and where should we be going?
Xunrong Luo, Kevan C Herold, Stephen D Miller. Immunity 2010
96
21


Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
Maki Nakayama, Norio Abiru, Hiroaki Moriyama, Naru Babaya, Edwin Liu, Dongmei Miao, Liping Yu, Dale R Wegmann, John C Hutton, John F Elliott,[...]. Nature 2005
526
21

Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice.
Karine Thébault-Baumont, Danielle Dubois-Laforgue, Patricia Krief, Jean-Paul Briand, Philippe Halbout, Karine Vallon-Geoffroy, Joëlle Morin, Véronique Laloux, Agnès Lehuen, Jean-Claude Carel,[...]. J Clin Invest 2003
177
21

Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.
Chang-yun Hu, Daniel Rodriguez-Pinto, Wei Du, Anupama Ahuja, Octavian Henegariu, F Susan Wong, Mark J Shlomchik, Li Wen. J Clin Invest 2007
297
21

Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Mark D Pescovitz, Carla J Greenbaum, Heidi Krause-Steinrauf, Dorothy J Becker, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Jennifer B Marks, Paula F McGee, Antoinette M Moran,[...]. N Engl J Med 2009
639
21

CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
Ania Skowera, Richard J Ellis, Ruben Varela-Calviño, Sefina Arif, Guo Cai Huang, Cassie Van-Krinks, Anna Zaremba, Chloe Rackham, Jennifer S Allen, Timothy I M Tree,[...]. J Clin Invest 2008
279
21

Immune cell crosstalk in type 1 diabetes.
Agnès Lehuen, Julien Diana, Paola Zaccone, Anne Cooke. Nat Rev Immunol 2010
301
21

Genetics, pathogenesis and clinical interventions in type 1 diabetes.
Jeffrey A Bluestone, Kevan Herold, George Eisenbarth. Nature 2010
675
21

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
Nicole Sherry, William Hagopian, Johnny Ludvigsson, Sunil M Jain, Jack Wahlen, Robert J Ferry, Bruce Bode, Stephen Aronoff, Christopher Holland, David Carlin,[...]. Lancet 2011
292
21

Short-term subcutaneous insulin treatment delays but does not prevent diabetes in NOD mice.
Vedran Brezar, Slobodan Culina, Marie-Claude Gagnerault, Roberto Mallone. Eur J Immunol 2012
12
50

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.
A Pugliese, M Zeller, A Fernandez, L J Zalcberg, R J Bartlett, C Ricordi, M Pietropaolo, G S Eisenbarth, S T Bennett, D D Patel. Nat Genet 1997
693
17

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
P Pozzilli, D Pitocco, N Visalli, M G Cavallo, R Buzzetti, A Crinò, S Spera, C Suraci, G Multari, M Cervoni,[...]. Diabetologia 2000
146
17

Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes.
F Susan Wong, Lai Khai Siew, Gwen Scott, Ian J Thomas, Stephen Chapman, Christophe Viret, Li Wen. Diabetes 2009
58
17

Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes.
Leonard C Harrison, Margo C Honeyman, Cheryl E Steele, Natalie L Stone, Elena Sarugeri, Ezio Bonifacio, Jennifer J Couper, Peter G Colman. Diabetes Care 2004
132
17

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
L Chaillous, H Lefèvre, C Thivolet, C Boitard, N Lahlou, C Atlan-Gepner, B Bouhanick, A Mogenet, M Nicolino, J C Carel,[...]. Lancet 2000
178
17

CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.
Roberto Mallone, Emanuela Martinuzzi, Philippe Blancou, Giulia Novelli, Georgia Afonso, Manuel Dolz, Graziella Bruno, Lucy Chaillous, Lucienne Chatenoud, Jean-Marie Bach,[...]. Diabetes 2007
148
17


Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Z J Zhang, L Davidson, G Eisenbarth, H L Weiner. Proc Natl Acad Sci U S A 1991
534
17

Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Balasubramanian Krishnamurthy, Nadine L Dudek, Mark D McKenzie, Anthony W Purcell, Andrew G Brooks, Shane Gellert, Peter G Colman, Leonard C Harrison, Andrew M Lew, Helen E Thomas,[...]. J Clin Invest 2006
168
17

Tolerance to proinsulin-2 is due to radioresistant thymic cells.
Béatrice Faideau, Chantal Lotton, Bruno Lucas, Isabelle Tardivel, John F Elliott, Christian Boitard, Jean-Claude Carel. J Immunol 2006
28
17

Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
F S Wong, J Karttunen, C Dumont, L Wen, I Visintin, I M Pilip, N Shastri, E G Pamer, C A Janeway. Nat Med 1999
350
17

Chromogranin A is an autoantigen in type 1 diabetes.
Brian D Stadinski, Thomas Delong, Nichole Reisdorph, Richard Reisdorph, Roger L Powell, Michael Armstrong, Jon D Piganelli, Gene Barbour, Brenda Bradley, Frances Crawford,[...]. Nat Immunol 2010
257
17

T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
Roberto Mallone, Vedran Brezar, Christian Boitard. Clin Dev Immunol 2011
52
17

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
Bart Keymeulen, Evy Vandemeulebroucke, Anette G Ziegler, Chantal Mathieu, Leonard Kaufman, Geoff Hale, Frans Gorus, Michel Goldman, Markus Walter, Sophie Candon,[...]. N Engl J Med 2005
789
17

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Diane K Wherrett, Brian Bundy, Dorothy J Becker, Linda A DiMeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Kevan C Herold, Jennifer B Marks,[...]. Lancet 2011
228
17

Development of type 1 diabetes despite severe hereditary B-cell deficiency.
S Martin, D Wolf-Eichbaum, G Duinkerken, W A Scherbaum, H Kolb, J G Noordzij, B O Roep. N Engl J Med 2001
194
14

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
Janet M Wenzlau, Kirstine Juhl, Liping Yu, Ong Moua, Suparna A Sarkar, Peter Gottlieb, Marian Rewers, George S Eisenbarth, Jan Jensen, Howard W Davidson,[...]. Proc Natl Acad Sci U S A 2007
618
14

Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy.
M A Atkinson, N K Maclaren, R Luchetta. Diabetes 1990
294
14




Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.
Hiroaki Moriyama, Norio Abiru, Johanna Paronen, Kamila Sikora, Edwin Liu, Dongmei Miao, Devasenan Devendra, Joshua Beilke, Roberto Gianani, Ron G Gill,[...]. Proc Natl Acad Sci U S A 2003
150
14

Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.
Kendra Vehik, David Cuthbertson, Holly Ruhlig, Desmond A Schatz, Mark Peakman, Jeffrey P Krischer. Diabetes Care 2011
71
14

HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.
Janelle A Noble, Ana Maria Valdes, Michael D Varney, Joyce A Carlson, Priscilla Moonsamy, Anna Lisa Fear, Julie A Lane, Eva Lavant, Rebecca Rappner, Anthony Louey,[...]. Diabetes 2010
148
14

Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes.
Andréa Toma, Taghrid Laïka, Samy Haddouk, Sandrine Luce, Jean-Paul Briand, Luc Camoin, Francine Connan, Marion Lambert, Sophie Caillat-Zucman, Jean-Claude Carel,[...]. Diabetes 2009
33
14

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.
Kirsti Näntö-Salonen, Antti Kupila, Satu Simell, Heli Siljander, Tiina Salonsaari, Anne Hekkala, Sari Korhonen, Risto Erkkola, Jukka I Sipilä, Lotta Haavisto,[...]. Lancet 2008
243
14

Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.
Scott M Lieberman, Anne M Evans, Bingye Han, Toshiyuki Takaki, Yuliya Vinnitskaya, Jennifer A Caldwell, David V Serreze, Jeffrey Shabanowitz, Donald F Hunt, Stanley G Nathenson,[...]. Proc Natl Acad Sci U S A 2003
298
14

Analysis of islet inflammation in human type 1 diabetes.
A Willcox, S J Richardson, A J Bone, A K Foulis, N G Morgan. Clin Exp Immunol 2009
416
14

Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.
Jacqueline D Trudeau, Carolyn Kelly-Smith, C Bruce Verchere, John F Elliott, Jan P Dutz, Diane T Finegood, Pere Santamaria, Rusung Tan. J Clin Invest 2003
189
14

Therapy to prevent type 1 diabetes mellitus.
Jean-Claude Carel, Paul Landais, Pierre Bougnères. N Engl J Med 2002
10
40

Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.
Tihamer Orban, Klara Farkas, Heyam Jalahej, Janos Kis, Andras Treszl, Ben Falk, Helena Reijonen, Joseph Wolfsdorf, Alyne Ricker, Jeffrey B Matthews,[...]. J Autoimmun 2010
79
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.